Published on 24/12/2025
Best Practices for Avoiding Confusion with Version Naming Conventions
Why Version Naming Conventions Matter in Clinical Trials
Inconsistent or unclear version naming can create confusion, protocol deviations, and even inspection findings. Whether it’s a protocol, informed consent form (ICF), SOP, or training material, each document must be named and versioned in a standardized, traceable manner.
Regulatory agencies such as the USFDA and EMA require sponsors and CROs to demonstrate a clear document lifecycle. Using structured naming conventions ensures traceability, improves communication with sites, and enhances TMF organization.
Step 1: Define a Naming Convention SOP
A well-documented SOP for naming conventions should include:
- Document type identifier: e.g., “Protocol”, “ICF”, “SOP”
- Study or project code: e.g., “ABC123”
- Version number: e.g., “v1.0”, “v1.1”, “v2.0”
- Date format: e.g., “01Jan2025” or “2025-01-01”
- Status label: “Final”, “Draft”, “Superseded”
Example: Protocol_ABC123_v1.1_2025-01-10_Final.pdf
Step 2: Avoid Common Pitfalls in Version Labeling
- Mixing “v1”, “v1.0”, “ver1” without standardization
- Skipping version numbers or mislabeling amendments
- Using internal codes that aren’t publicly understandable
- Failing to update filenames even after changes are made
- Missing “Draft” or “Final” labels, causing file misusage
Consistency is key. Train document owners and CRA teams to use only the SOP-defined format.
Step 3: Standardize Naming for Amendments and Updated Documents
When a protocol or SOP is amended, version naming must clearly reflect the nature of the change. Suggested formats include:
- v1.0: Initial version
- v1.1: Minor amendment
- v2.0: Major amendment
- v2.1: Minor update post v2.0
The file name should also reflect the amendment number, where relevant. For example:
Protocol_ABC123_v2.0_Amendment2_2025-04-20_Final.pdf
This clarity helps both sponsors and sites avoid using outdated versions and prevents non-compliance due to document confusion.
Step 4: TMF Organization and Version Clarity
TMF structure relies heavily on consistent document versioning. Each new protocol or ICF version must be filed under:
- 01.07.01: Protocol and Amendments
- 01.08.01: Informed Consent Forms
- 05.03.06: Site Training Documentation (for updates)
Version-controlled filenames help TMF reviewers easily identify current vs. superseded documents. Consistent naming across systems also enables automated document indexing in modern eTMF platforms.
Step 5: CRA Monitoring and CTMS Alignment
CRAs often verify document versions during site monitoring visits. Having clear naming conventions ensures:
- CRAs can confirm sites are using the latest approved version
- Monitoring reports accurately reference version numbers
- Training logs can reference exact document titles
Moreover, CTMS systems should mirror the same naming conventions. Misalignment between eTMF and CTMS versions can cause confusion and audit observations.
Real-World Inspection Scenario
During a EMA inspection of a Phase II oncology trial, investigators discovered that two protocol versions were both labeled “v2.0,” despite one being a draft and one final. The absence of a “Draft” label led to the wrong version being implemented at 3 sites.
The finding resulted in a major deviation classification and required extensive CAPA, retraining, and documentation correction. The root cause was traced back to inconsistent naming practices and lack of SOP enforcement.
Conclusion: Naming Conventions Are Small But Critical
Version naming may seem administrative, but in clinical research, it plays a key role in ensuring data integrity, operational consistency, and regulatory compliance. A structured naming convention, backed by SOPs, trained staff, and system-wide implementation, helps prevent confusion and supports inspection readiness.
To implement audit-ready naming and versioning SOPs in your study, explore templates and guidance at PharmaValidation.in and PharmaSOP.in.